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A Polymorphic Genomic Duplication on Human
Chromosome 15 Is a Susceptibility Factor
for Panic and Phobic Disorders
age of onset of 20 years, and a higher risk for females
(2-fold) (Weissman et al., 1997; Weiller et al., 1998). Panic
disorder is often associated with other anxiety disorders
(80%), such as social and simple phobia, and with de-
pression (30%) (Barlow et al., 1986). Several million peo-
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The search for susceptibility genes for panic disorderSummary
has been focused on candidates for its pathophysiology,
such as adrenergic, dopamine, -aminobutyric acid, andAnxiety disorders are complex and common psychiat-
nicotinic acetylcholine receptors, monoamine oxidaseric illnesses associated with considerable morbidity
A (MAO-A), and cholecystokinin (CCK). Putative associ-and social cost. We have studied the molecular basis
ations have been detected for MAO-A (Deckert et al.,
of the cooccurrence of panic and phobic disorders
1999) and CCK (Kennedy et al., 1999; Wang et al., 1998).
with joint laxity. We have identified an interstitial dupli- Genome-wide scans have so far failed to identify a major
cation of human chromosome 15q24-26 (named DUP25), susceptibility locus for panic disorder (Knowles et al.,
which is significantly associated with panic/agorapho- 1998; Weissman et al., 2000; Crowe et al., 2001), and
bia/social phobia/joint laxity in families, and with panic this has been attributed to both locus heterogeneity and
disorder in nonfamilial cases. Mosaicism, different complexity of the phenotypes.
forms of DUP25 within the same family, and absence Among the biological variables studied in panic disor-
of segregation of 15q24-26 markers with DUP25 and der, joint laxity or joint hypermobility syndrome has
the psychiatric phenotypes suggest a non-Mendelian yielded particularly interesting results. Joint laxity is a
mechanism of disease-causing mutation. We propose clinical condition characterized by an increased disten-
that DUP25, which is present in 7% control subjects, sibility and hypermobility of joints. Joint laxity shows a
is a susceptibility factor for a clinical phenotype that female/male ratio of 3:1, a dominant pattern of inheri-
includes panic and phobic disorders and joint laxity. tance, and a prevalence of 10%–15% (Beighton, 1989).
Joint laxity is a feature common to several hereditary
diseases of the connective tissue, but a specific jointIntroduction
laxity gene has not been identified.
A strong association between joint laxity and anxietyAnxiety disorders are heterogeneous psychiatric condi-
disorders was described by Bulbena et al. (1988). Basedtions. In panic disorder, anxiety manifests as recurrent,
on a case-control study in rheumatological patients, itunexpected panic attacks and associated avoidance
was reported that panic disorder, agoraphobia, and sim-and worry related to the possible recurrence, conse-
ple phobia were four times more common in patientsquences, or health implications of the attacks. One-third
with joint laxity than in controls (Bulbena et al., 1993).to one-half of patients with panic disorder also have
A second case-control study, carried out in psychiatricagoraphobia. Epidemiological data of panic disorder
patients, found that joint laxity was 16-fold more com-have reported lifetime prevalences of 1.6%–3%, mean
mon in patients with panic/agoraphobia than in controls
(Martı´n-Santos et al., 1998).
This clinical association between anxiety disorders5 Correspondence: estivill@iro.es
and joint laxity has also been confirmed in a community6 These authors contributed equally to this work
sample (Gago, J., Doctoral Thesis, 1992, unpublished).7 Present address: Instituto de Investigaciones Biome´dicas Alberto
Sols. CSIC-UAM, E-28029, Madrid, Spain After adjusting for age and gender, subjects with joint
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Figure 1. Genealogy of the Largest Pedigree (Family PH8) with 47 Members, 25 of whom Have Panic Disorder/Agoraphobia/Social Phobia/
Simple Phobia/Joint Laxity
laxity were significantly more likely to suffer from panic An Interstitial Duplication of Chromosome
15q24-26disorder (OR 8.19; 95% CI 3.41–19.67), agoraphobia
(OR  5.89; 95% CI  2.98–11.66) and social phobia Cooccurrence of several anxiety disorders with joint lax-
ity suggested the possibility that they might share a(OR  7.79; 95% CI  2.44–24.85). Several genealogies
in which panic disorder and social phobia cooccurred common genetic alteration. Prior to a genome-wide
analysis, we performed a cytogenetic study in 10 pa-with joint laxity were observed in this community sam-
ple. Cosegregation of traits in affected subjects and/or tients, mainly focused on excluding chromosome re-
arrangements. A putative alteration on chromosome 15families should help to define candidate chromosome
regions. We present here the identification of a polymor- was identified, consisting of a slight difference in size
between the homologs, together with a different G-band-phic interstitial duplication of chromosome 15q24-26 in
individuals of families affected by an expanded anxiety ing pattern at 15q24-26 in some metaphases. This chro-
mosome region was characterized by FISH using YACphenotype that includes panic/phobic disorders/joint
laxity, and in an independent sample of patients with clones. YACs 753h11, 891e7, 750b10, 929c7, and 802b4
revealed an interstitial duplication at 15q24-26 (namedpanic disorder. Genetic features of this genomic muta-
tion indicate that it may be a novel mutational mecha- DUP25) in all samples (Figure 2).
We derived cosmid probes (t216-1 and c251-3) fromnism involved in human disease, and we propose that
it is a factor of genetic susceptibility for panic and phobic PACs 216i14 and 252a23, located at the ends of DUP25.
FISH analysis of all available samples (n  93) led to thedisorders.
detection of DUP25 in 67 subjects (72%). Three different
forms of DUP25 were identified (Figure 2). The mostResults
common duplication was considered to be “telomeric”
and was found in 53 subjects (79%). This telomeric dupli-Pedigrees with Anxiety Disorders and Joint Laxity
Seven genealogies with multiple members affected by cation was observed in a direct (39%) and in an inverted
(61%) form. A “centromeric” duplication (direct), withpanic/phobic disorders and joint laxity were identified
(Figure 1). Twenty patients had panic disorder (10 with- the probe signals at 15q22, was detected in 11 subjects
(16%). Finally, cells from three patients (5%) carried bothout agoraphobia and 10 with agoraphobia), 8 had agora-
phobia, 32 social phobia, 50 simple phobia, and 65 joint the telomeric (two inverted and one direct) and the cen-
tromeric duplication.laxity. Several subjects had more than one phenotype
and there was a clear concentration of affected subjects DUP25 was analyzed in three control groups (n 
189). DUP25 was detected in 5 of 81 (6%) anonymousamong the seven families. The prevalences of panic
disorder/agoraphobia (19%), social phobia (22%), sim- amniotic fluid samples from unrelated pregnancies, in
5 of 54 (9%) adult unrelated individuals, and in 4 of 54ple phobia (34%), and joint laxity (44%) in the families
were significantly higher than those in the village (p  unrelated samples of the CEPH families (7%). Among
the 14 control samples with DUP25 (7%), 10 were telo-0.0001), which do not differ from those reported in the
general population (Weiller et al., 1998). Joint laxity meric (4 direct and 6 inverted) and 4 were centromeric.
Mosaicism for DUP25 was first observed in lympho-cooccurred with panic disorder/agoraphobia in 64%
of patients, social phobia in 59%, and simple phobia cyte metaphasic chromosomes and was scored in in-
terphase nuclei with the same probes used for meta-in 46%.
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Figure 2. Identification and Characterization of DUP25 by FISH with YAC and Cosmid Probes in Patients with Panic Disorder and Joint Laxity
(A) G-banding of a metaphase from a subject with the 15q24-26 duplication. (B) FISH analysis of the same metaphase shown in (A), with YAC
750b10 (chromosome 15, arrowed) and YAC 230e8 (chromosome 21). (C) FISH analysis of the same sample with cosmid probes t216-1 and
c251-3 and the same control probe as in (B). DUP25 chromosomes show a double hybridization signal at 15q24-26 for each of the cosmid
probes. (D) Chromosome 15 homologs of a patient with the centromeric duplication (15q22). (E) Chromosome 15 homologs of a patient with
the telomeric inverted DUP25 in homozygosity.
phase studies, yielding a mean of 59% cells with DUP25 being 37% for panic disorder (with or without agorapho-
bia), 40% for social phobia, 48% for simple phobia and(range 56%–62%, CI 95%) (Figures 3A–3D).
DUP25 was detected in 30%–60% of the spermatozoa 63% for joint laxity. Overall, 20% of subjects with DUP25
did not have any anxiety phenotypes.of patients (n  12) bearing the duplication in their lym-
phocytes, but was not found in control subjects (n  4) Table 1 shows the lod score values for two-point link-
age analysis between DUP25, under two levels of pene-(Figures 3E and 3F). There was no correlation between
the percentage of duplicated cells in lymphocytes and trance, and 11 models of the clinical phenotype. The
highest significant lod score value was 5.0 for the modelsperm.
Although no other structural cytogenetic abnormali- that includes panic disorder/agoraphobia/social pho-
bia/joint laxity. When joint laxity was considered by itselfties were observed, we studied chromosomal stability
in four DUP25 patients. The rate of sister-chromatid it gave a lod score of 3.82. None of the models consider-
ing each psychiatric disorder alone reached significantexchanges was within the expected values (4% to 6%)
in normal subjects, and these were not specifically de- lod score values, but lod scores near 3 were obtained
for the models with four anxiety phenotypes and overtected in any acrocentric chromosome.
3 for panic/agoraphobia/social phobia in the affecteds-
only analysis. The addition of joint laxity to the anxietyLinkage and Association between DUP25
and Anxiety and Joint Laxity phenotypes led to lod score values higher than 3 for all
the models with the exception of simple phobia.Ninety percent of patients diagnosed with one or several
anxiety disorders had the duplication. Remarkably, all We also studied all the possible pairs of affected indi-
viduals that share the duplication alleles inherited identi-patients with panic disorder with or without agorapho-
bia, and all patients with social phobia, carried DUP25. cal by descent (IBD). In all models but one (simple phobia
alone) we obtained significant evidence of associationDUP25 was found in 87% of subjects with joint laxity.
Conversely, the penetrance of DUP25 was not complete, between the psychiatric phenotypes and DUP25 (Table
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Figure 3. FISH Analysis in Interphase Nuclei
of Lymphocytes and Sperm Heads of Pa-
tients with Panic Disorder and Joint Laxity
(A) Two interphase nuclei (G1 stage) of a pa-
tient with DUP25 hybridized with cosmid
t216-1 and a control cosmid of chromosome
21. (B) Interphase nucleus in G2 stage, show-
ing heterozygosity for DUP25. (C) An in-
terphase nucleus in G2 stage, showing four
FISH double signals, and indicating homozy-
gosity for DUP25. (D) Two nuclei (G1 stage)
with three and two hybridization signals, indi-
cating mosaicism for DUP25. (E and F) FISH
analysis of DUP25 in the sperm of a patient
with panic disorder and joint laxity. (E) Hybrid-
ization with probes c251-3 and t216-1 show-
ing two normal spermatozoa and one carrying
DUP25. (F) FISH in a sperm head of the same
patient. Probe t216-1 shows the duplication,
while probe 230e8 (21q) shows only one
signal.
1). The significance of the association with DUP25 was Non-Mendelian Inheritance of DUP25
Despite the strong association and linkage betweenconsiderably increased when joint laxity was added to
the psychiatric phenotypes. DUP25 and the panic and phobic disorders and joint
laxity phenotypes, the analysis of the families with mark-We replicated these findings in a set of 70 unrelated
patients with panic disorder/agoraphobia. Remarkably, ers located within and flanking DUP25 gave Zmax values
between 0 (  0.5) and 0.85 (  0.1) for the phenotypeDUP25 was detected in 68 patients, in contrast to 14
samples with the duplication detected among the 189 that includes any anxiety disorder/joint laxity. Also, link-
age between DUP25, considered as a phenotypic trait,control samples (2  185.9, with Yate’s correction; p 
0.0001). and these markers gave Zmax values between 0 (  0.5)
and 0.96 (  0.2). The four markers within DUP25 spanSince the association between DUP25 and the studied
phenotypes was so striking, two blind studies with a about 10 cM in these families, in agreement with dis-
tances described in the CEPH families (http://www.total of 50 samples (25 DUP25 and 25 controls) were
performed. Two independent cytogeneticists analyzed cephb.fr/), which proves the consistence of the analysis
and the absence of typing errors.the coded samples hybridized with two DUP25 probes
and sent the results to a third party. DUP25 was found Besides this absence of linkage with DNA markers,
several cases of abnormal segregation of DUP25 werein 92% of duplicated samples and in 8% of wild-type
samples. Failures in the detection occurred for samples observed. Figure 4 shows the generation of a de novo
case of DUP25, the apparent “reversion” from dupli-in which only one probe could be read and/or the propor-
tion of DUP25 cells was low. cated to nonduplicated chromosomes, and the apparent
Genomic Chromosome 15 Duplication in Anxiety Disorders
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Table 1. Parametric and Nonparametric Analyses for Panic Disorder, Agoraphobia, Social Phobia, Simple Phobia, and Joint Laxity
with DUP25 in Seven Families
Pairwise Lod Score Affecteds-only Lod Score Extended Relative Pair Analysis
Phenotype Partial Pen. Full Pen. Partial Pen. Full Pen. Shared Alleles Unshared Alleles 2 P
PD/A/SoPh/SiPh/JL 3.33 3.16 2.88 2.64 E 61.60 124.23 15.73 0.0001
O 86.60 99.24
PD/A/SoPh/SiPh 1.89 1.45 2.96 2.92 E 44.64 87.02 13.29 0.0003
O 64.43 67.22
PD/A/SoPh/JL 4.94* 5.00* 3.66 3.66 E 52.81 105.20 16.38 0.00006
O 76.82 81.59
PD/A/SoPh 2.04 1.83 3.36 3.71 E 52.83 105.52 12.27 0.0005
O 73.61 84.82
PD/A/JL 4.29* 4.28* 3.10 3.16 E 46.67 92.50 15.85 0.00007
O 68.84 70.32
PD/A 0.50 0.58 1.63 1.84 E 13.43 21.71 5.78 0.02
O 20.36 14.79
SoPh/JL 4.16* 3.92 3.28 3.28 E 48.19 94.50 14.69 0.0002
O 69.84 72.84
SoPh 0.02 0.09 2.00 2.36 E 11.28 23.71 8.36 0.004
O 19.28 15.72
SiPh/JL 2.33 2.01 2.63 2.42 E 59.68 118.37 11.01 0.001
O 80.58 97.47
SiPh 0.28 0.59 1.37 1.40 E 22.19 44.47 3.58 0.06
O 29.47 37.49
JL 3.82 3.79 2.78 2.88 E 40.19 77.81 15.75 0.00008
O 60.62 57.38
PD, panic disorder; A, agoraphobia; SoPh, social phobia; SiPh, simple phobia; and JL, joint laxity. All values are Zmax at   0. Partial Pen.
and Full Pen. correspond to the two models of high and almost complete penetrance of DUP25; E, expected; O, observed; *, significant lod
score values (4.1) under the 11 studied models.
“conversion” of one form of the duplication to the other. region of the centromeric DUP25, and another maps
to 15q26.3. The 15q24-25 region also contains severalRemarkably, we never detected three alleles for markers
within DUP25, even when the duplication was present clusters of LCR15 sequences. Finally, several LCR15
copies map to the 15q11-13 region, involved in Prader-in three generations.
Willi and Angelman syndrome deletions (PWS/AS), inv
dup(15), and other rearrangements of this chromosomeChromosome 15 Specific Duplicons Flank
the Region Containing DUP25 region.
Figure 6B shows the alignment of DNM1 sequences,A YAC/PAC contig covering the 15q24-26 region was
constructed (Figure 5). The duplicated region spans revealing identities95%. The region of sequence iden-
tity spans at least 20 kb for regions flanking and withinmarkers D15S1085 (proximal) and WI-7222 (distal). The
proximal end of the duplication was located between DUP25. Since these contig sequences still contain many
gaps, and the order of fragments has not yet been estab-YACs 875a3 and 33i-F3 (not overlapping), and the distal
end between YACs 966a2 and 911b8 (not overlapping). lished for several regions, the final length and identity
will only be precisely determined once the sequencing ofData from Genebridge 4 and Stanford G3 radiation hy-
brid panels indicate a DUP25 size of about 60 cR and the regions is complete. BAC clones containing LCR15
copies showed FISH signals on 15q24 and 15q26, con-600 cR, respectively, corresponding to about 14 Mb.
From the size of nonchimeric YAC and PAC clones, a firming the identity between these regions. Hybridization
under less stringent conditions also allowed the detec-physical distance of about 10 Mb can be estimated.
According to the contig of the draft of the human ge- tion of signals on 15q11-13 and 15q22, where the centro-
meric form of DUP25 is located (Figure 6C).nome sequence, the size of DUP25 is about 17 Mb, and
contains at least 59 known genes and a large number
of ESTs and uncharacterized mRNAs. Gene Dosage and Overexpression
of Chromosome 15q24-26 GenesWe have identified several low copy repeat (LCR15)
sequences at several regions of human chromosome Dosage for genes within DUP25 was expected to be
increased, as compared to normal subjects and to genes15 (Pujana et al., 2001). These are located on 15q11-
13, 15q22, 15q24, 15q25, and 15q26 (Figure 6A), have located outside the duplicated region or on other chro-
mosomes. The neurotrophin 3 receptor (NTRK3) gene,lengths of between 13 and at least 60 kb, and share a
sequence identity 90% over their length. LCR15 cop- contained within DUP25, was assessed for dosage anal-
ysis. Figure 7A shows the comparative Southern blottingies contain three expressed pseudogenes (Golgin-like
protein, GLP; SH3 domain-containing protein, SH3P18; analysis of NTRK3 and the rBAT control probe on chro-
mosome 2p. Quantification and peak height clearly indi-and Dynamin 1, DNM1). LCR15 sequences flanking the
DUP25 region are within the contig sequences from cate increased band intensity in individuals carrying
DUP25. PCR coamplification of a fragment of NTRK3GenBank named NT_010298 (15q24.1) and NT_024746
(15q26.1). One LCR15 copy is located at 15q22, in the and a control fragment of the PROC gene (chromosome
Cell
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Figure 4. Segregation of Microsatellite Markers within the 15q24-26 Region and Analysis of DUP25 in Partial Pedigrees of Two Families with
Panic Disorder and Joint Laxity
The most likely haplotypes segregating in the families are indicated. The genotypes for DUP25 are shown (T, telomeric; C, centromeric; W,
wild-type chromosome; d, direct; and i, inverted). The percentage of duplicated cells is indicated in brackets. *, sample and clinical data not
available. (A) Partial pedigree of family PH8 showing a de novo case (IV-15), an apparent “reversion” (IV-17), and a possible “conversion” (IV-
18) of DUP25. (B) Partial pedigree of family PH2 with an apparent “reversion” from DUP25 to normal (III-2) and a putative “conversion” from
the telomeric inverted to the direct form of DUP25 (III-1).
2q) showed the expected dosage differences (Figure may modulate the effect of DUP25. Second, DUP25
could be a common susceptibility factor that would7B). To analyze if there was overexpression of genes
contained in the 15q24-26 duplicated region, we se- manifest itself in a clinical disorder depending on the
action of other genes. Third, mosaicism can also ac-lected IL16, which maps within DUP25 and is sufficiently
expressed in lymphocytes. As expected, subjects with a count for the clinical variability of these disorders. An
interaction between these three factors is likely to occur.high proportion of cells with DUP25 showed higher levels
of IL16 cDNA as compared to controls (Figure 7C). Due to the special features of DUP25, it is not surpris-
ing that it was not previously identified. Despite its large
size, the duplication is not easily detectable by conven-Discussion
tional cytogenetics, and its presence in mosaicism might
be interpreted as an artifact, appearing only in someAn Interstitial Chromosome Duplication
Associated with Anxiety Disorders metaphases. Furthermore, data of the sequence of the
human genome has revealed the presence of a largeWe have identified an interstitial duplication of chromo-
some 15q24-26 and found it associated with several number of both intrachromosomal and interchromo-
somal segmental duplications affecting all chromo-anxiety disorders, confirming their heritable condition
(although non-strictly Mendelian) and supporting a com- somes (International Human Genome Sequencing Con-
sortium, 2001; Venter et al., 2001). These segmentalmon biological cause. The detection of DUP25 in most
subjects of an independent sample of unrelated panic duplications provide many targets for mutations such
as the one described here, which could also apply fordisorder patients reinforces the idea that DUP25 is a
susceptibility mutation for these anxiety phenotypes. other complex genetic disorders.
DUP25 is present in 7% of control samples, and the
penetrances for the studied phenotypes range between DUP25 Is a Genomic Mutation Flanked
by LCR15 Duplicons37% and 63%. Several possibilities can be considered
to explain the incomplete penetrance of DUP25. First, The different forms of DUP25 always involve the same
chromosome region, flanked by several LCR15 copiesnongenetic factors such as age, sex, and environment
Genomic Chromosome 15 Duplication in Anxiety Disorders
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Figure 5. Physical Map of the 15q24-26 Region
The minimum size of the duplicated region is based on the YAC contig, radiation hybrid panel and genetic map. The centromeric (CEN) and
telomeric (TEL) ends are indicated. Markers are spaced at equal intervals. The 49 STSs spanning the duplicated region are noted above the
blue horizontal bar. Blue circles in the YACs and PACs represent STSs contained in the clones, and the white circles the absent ones. Filled
horizontal bars indicate the location of genes within YAC or PAC clones that have been mapped under this project. FISH probes are indicated
as red and green squares and PAC numbers are preceded by P.
(Pujana et al., 2001), such as those detected in several there are specific orientations of LCR15 sequences that
have a higher susceptibility to suffer rearrangements,genomic disorders (reviewed in Lupski, 1998; Ji et al.,
2000). The vast majority of these repeated sequences as detected in other genomic mutation disorders (Giglio
et al., 2001).contain genes or pseudogenes and recombination-pro-
moting features, and have been named “duplicons” There are two main differences between DUP25 and
the duplications of CMT1A and the reciprocal duplica-(Eichler, 1998). Duplicons seem to be involved in the
deletions that cause PWS/AS, Williams-Beuren syn- tion of the SMS deleted region. These duplications have
mainly a meiotic origin, where three alleles for micro-drome (WBS), DiGeorge/velo-cardio-facial syndrome
(VCFS), and neurofibromatosis type 1. Deletions and the satellite markers are often detected, and there is no
evidence of mosaicism for the duplication in these disor-corresponding duplications have been found for Smith-
Magenis syndrome (SMS) and Charcot-Marie-Tooth 1A ders. The absence of three alleles for markers within the
duplicated region in any subject bearing DUP25 practi-(CMT1A), and the recurrent inverted duplication of the
short arm of human chromosome 8, inv dup(8p) (Giglio cally excludes unequal crossing-over between homolo-
gous chromosomes during meiosis as the major mecha-et al., 2001), among others. These rearrangements seem
to be caused by unequal recombination events medi- nism causing the duplication. Thus, the duplication
probably arises during mitosis by either intrachromoso-ated by the high sequence identity between copies of
the same duplicon. Similarly to the DUP25 mutation, the mal or interchromosomal unequal crossing-over events.
The mitotic origin is also supported by the presence ofduplicons of DiGeorge/VCFS, WBS, and PWS/AS are
present in several copies flanking the respective re- mosaicism, as it has recently been described for an
interchromosomal repeat rearrangement involving chro-arranged regions.
The presence of LCR15 duplicons with several copies mosomes 4 and 10 (van Overveld et al., 2000).
It is difficult to determine how mosaicism for DUP25 isof potentially transcriptionally active large repeat units
flanking DUP25, and of additional copies in other regions generated in the patients. DUP25 is perhaps lost during
DNA replication through successive mitoses, leading toof chromosome 15q, specially on 15q22 (where the cen-
tromeric DUP25 is found), provides clues about how different proportions of duplicated cells depending on
the mitotic index of the tissue, but DUP25 could alsothese different rearrangements arise. It is possible that
Cell
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Figure 7. Dosage Analyses for Genes Located within the 15q24-26 Region in Subjects with Anxiety Disorders and Joint Laxity
(A) Southern blot analysis of EcoRI-digested genomic DNA from a normal control, two DUP25 “heterozygous” patients, and a “homozygous”
patient, with probe pNIJ3-SR0.4 (NTRK3) and the control probe E7-rBAT (rBAT). The relative intensities of the peaks for each probe are
indicated by the vertical arrows. P.I., pixel intensity. The genotypes are n/n for the normal subject, T/n for the heterozygote for the telomeric
DUP25, and T/C for a compound heterozygote for the telomeric and centromeric DUP25. (B) Chromatograms of the quantitative PCR analysis
of the NTRK3 and PROC genes of a control individual and DUP25 patients. PCR reactions were performed in a volume of 10 l and 22 cycles
with fluorescently labeled primers. Primers were for NTRK3 TrK3U2, 5	-tatgaagatgttcgcttcag-3	 and TrK3U2F, 5	-tctacctggacattcttggct-3	;
and for PROC PC111, 5	-gtgctagtgccactgtttgt-3	 and PC112, 5	-atcaccacctagctctcttc-3	. The height ratio was 1.4-fold higher for a heterozygous
subject and 2.5-fold for a homozygous subject versus a normal control. (C) Quantitation of the human IL16 mRNA expression in cultured cell
lines from a patient homozygous for DUP25 and from a normal subject. The upper band corresponds to the target cDNA (IL16) and the lower
fragment to varying dilutions of the internal standard (I.St.). Lanes C1 to C3 correspond to the I.St., IL16 and blank controls, respectively, and
M, marker. The equivalence point for a 1:1 ratio between IL16 and I.St. in the control individual lies between 9.6 and 2.8 attomoles; and in
the homozygous patient between 32 and 19.2 attomoles. The logarithm of the ratio of integrated optical density of IL16 vs the I.St. (L) was
plotted against the amount of total I.St. included in the PCR reaction. Vertical arrows indicate the equivalence point (ratio 1:1 or log101  0)
of each sample. Genotypes are as in (A) and (B).
arise early during development, leading to different pro- et al., 1968) or that specific arrangements of duplicons
are specially prone to mutate (paramutable locus), caus-portions of cell populations. Despite DUP25 being pres-
ent in spermatozoa, indicating that it could be transmit- ing DUP25 during embryogenesis. The failure to detect
linkage for panic disorder in whole genome analysested through generations, this does not necessarily mean
that embryos with all cells carrying DUP25 are viable. could be due to these non-Mendelian features of DUP25,
which should make the identification of the panic disor-Several characteristics of DUP25 suggest that we are
facing a non-Mendelian mutation mechanism causing der locus very difficult by linkage, sib-pair, or associa-
tion analyses using DNA markers. The use of DUP25 asdisease: first, the absence of linkage of DUP25 and the
psychiatric and joint laxity phenotypes with markers a diagnostic tool and the inclusion of joint laxity in the
phenotype definition of the patients should facilitate thefrom the 15q24-26 region, with cases of apparent rever-
sions and conversions, as well as de novo cases of detection of linkage in large sets of families.
DUP25; and second, the presence of mosaicism and
the detection of different forms of DUP25 in subjects DUP25 Candidate Genes for Panic/Phobic
Disorders and Joint Laxityof the same family and in the same individual. These
observations raise the possibility that another locus The mechanism by which the 15q24-26 duplication
leads to panic and phobic disorders and joint laxity ismight be governing DUP25 (paramutagenic locus, Brink
Figure 6. Sequence Similarity and Chromosome 15 Localization of LCR15 Duplicons
(A) BlastN analysis of the draft sequence of the human genome with a partial sequence of the DNM1 gene. Most hits were detected on
chromosome 15 (q11-13, q22, q24-25 and q26). The relative positions of the blast hits in the figure do not fully correspond to the bands in
the ideogram. (B) CLUSTAL W alignment of a fragment of 60 nucleotides of DNM1 sequences. (C) FISH signals obtained with BAC RP11-
152F13, containing LCR15 sequences. Hybridization to the Y chromosome was also observed as described previously (Pujana et al., 2001).
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probably through a dosage effect, with overexpression orders, and it is likely that its identification should have
important implications for psychiatry and health.of one or several genes of DUP25. Alternatively, the
phenotype could be caused by the disruption of genes Since we have shown that several anxiety and joint
laxity phenotypes share the same susceptibility muta-at the duplication breakpoints. Among the known genes
within the DUP25 region, those with a possible role in tion and, therefore, are part of the same clinical pheno-
type, it should be instructive to study other phenotypesthe pathophysiology of these disorders should be con-
sidered. that could be related to these disorders, such as separa-
tion anxiety and phobic and avoidance traits, amongOne good candidate for anxiety disorders is the gene
that encodes the neurotrophin-3 receptor, NTRK3 (Lam- others. This would be in line with the concept of “endo-
phenotypes,” which are traits associated with the ex-balle et al., 1991). Among other functions, neurotrophins
have a role in plasticity of the nervous system (Schinder pression of an illness and might represent the genetic
liability of the disorder among nonaffected subjectsand Poo, 2000) and may mediate changes in neural con-
nections associated with learning and memory (Kang and (Leboyer et al., 1998). These endophenotypes would
include a broad range of related symptoms that appearShuman, 1995). NTRK3 is abundantly expressed in the
noradrenergic neurons of the forebrain and is the only in patients with anxiety disorders. Detailed clinical epi-
demiological studies in the subjects bearing DUP25neurotrophin receptor detected in the locus coeruleus
(LC) (Merlio et al., 1992). The LC is the principal norepi- should reveal the extent of the clinical implications of
this common genomic duplication.nephrine (NE)-containing nucleus in the CNS, playing a
major role in behavioral arousal in response to novel or
stressful stimuli (Foote et al., 1983). Moreover, antide- Experimental Procedures
pressant drugs modify the levels of expression of neuro-
Subjects and Clinical Evaluationtrophins and their receptors, in particular neurotrophin-3
From a previous epidemiological study of anxiety disorders and(NT-3) (Smith et al., 1995). Since patients with panic
joint laxity performed in a village of 2,000 inhabitants near Barcelona,
disorder suffer from an abnormal sensitive fear network we identified seven families (n  178) with a high prevalence of
that includes areas of the brain such as the LC (Gorman panic disorder, social phobia, and joint laxity (Gago, J., Doctoral
Thesis, 1992, unpublished). Written informed consent was obtainedet al., 2000), the overexpression of NTRK3 in the LC
from 147 subjects. Diagnoses were made by two senior psychiatristsmight induce an excessive trophic and proliferative ef-
(R.M.-S. and E. del Moral) with the Structured Clinical Interviewsfect on NE neurons. Overactivity and enhanced efficacy
(SCID) of DSM-III-R criteria (American Psychiatric Association,of NE synapses would be the final consequence of the
1987). Children were explored with a specific protocol based on
NTRK3 overexpression, causing a decrease of the emo- DSM-III-R criteria. Interrater reliability for psychiatric diagnosis
tional arousal threshold of the individual, which in turn ranged between 0.65 and 1.00 (
 values). Different anxiety, depres-
sion, phobia and personality rating scales were also administered.would alter the alarm/fear regulatory system and, thus,
Difficult cases were reviewed by an independent senior psychiatristleading to panic attacks.
(A.B.), and a consensus diagnosis was made. The following diagno-The genes encoding three subunits of the nicotinic
ses were considered: panic disorder, agoraphobia, social phobia,acetylcholine receptor, A3 (CHRNA3), A5 (CHRNA5),
and simple phobia. In a blind manner with regard to the psychiatric
and B4 (CHRNB4), are clustered on human chromosome status, joint laxity was assessed by two trained general practitioners
15 (Eng et al., 1991). We have precisely mapped these (J.G. and K.R.) in all subjects, and affection was considered when
Beighton’s criteria score was  4. The interrater reliability of thegenes on the proximal end of the duplication, within the
different criteria ranged between 0.70 and 1 (
 values). We consid-rearranged region. A higher expression of these subunits
ered as a case all individuals who were psychiatrically affected ormay change their affinity for nicotine, thus affecting
had joint laxity. We obtained 135 samples for DNA analysis, 93 formany aspects of behavior (Fritze et al., 1995). It is possi-
FISH studies and 12 for sperm analysis.
ble that the final phenotypes are the result of the additive A sample of 70 consecutive outpatients of both sexes and older
effects of the overexpression of NTRK3, nicotinic recep- than 18 years, diagnosed with panic disorder with or without agora-
phobia by the SCID-DSM-III-R interview (R.M-S. and G.P.), was ob-tors, and other genes within DUP25.
tained from the Anxiety Unit at the Hospital del Mar. None of theLysyl oxidase-like (LOXL1) (Kenyon et al., 1993) is a
patients had any relation with the pedigree sample and all gavegene that maps within the DUP25 region and encodes
written informed consent to participate in the study.a protein that colocalizes in the extracellular matrix. It
Control samples consisted of 81 anonymous amniotic fluid sam-
is possible that the duplication of LOXL1 causes alter- ples from unrelated pregnant women that underwent prenatal diag-
ations in the intermolecular and intramolecular cross- nosis because of advanced maternal age, and 54 adult unrelated
individuals (the married-in subjects of patients that were studied forlinks of collagen and/or elastin fibers, through the defec-
other genetic disorders) for whom anxiety disorders and joint laxitytive formation of mature fibrils which could become
were not assessed. Lymphocytes of 27 couples corresponding tomore extensible and, thus, lead to the joint laxity phe-
parents of the CEPH families (54 unrelated samples) were also stud-notype.
ied. Control sperm was obtained from four subjects studied prior
to vasectomy. Protocols were approved by the Ethics and Research
Committees of both research institutes.DUP25 In the Context of Psychiatric Disorders
and Health
Anxiety disorders have a high prevalence and are the Cytogenetic and FISH Studies
FISH analysis was carried out in 93 samples from the families, inmost common cause of medical intervention in primary
70 unrelated patients with panic disorder, and in 189 control samplescare (Weiller et al., 1998). Anxiety disorders belong to
(see above). Samples were analyzed blindly as to clinical statusthe category of complex diseases for which intense re-
by two cytogeneticists. Chromosome spreads were obtained after
search efforts are focused on the identification of ge- harvesting a 72 hr lymphocyte culture from peripheral blood.
netic susceptibility factors. DUP25 is probably a major G-banding was performed according to standard procedures. All
probes used were labeled with either biotin-16dUTP or digoxigenin-genetic factor of susceptibility for panic and phobic dis-
Genomic Chromosome 15 Duplication in Anxiety Disorders
377
11dUTP (Boehringer-Mannheim) and FISH was performed as de- sets for the different phenotypic models. None of the replicates
reached lod score values higher than 3 (p  0.03) or 2 (p  0.03),scribed elsewhere (Nadal et al., 1997). For cDNA and cosmid probes,
biotin signals were amplified once. Slides were studied under a supporting the significance of the obtained lod score values.
The following chromosome 15q markers were studied: a micro-fluorescence microscope (AH3, Olympus) equipped with the appro-
priate filter set. Images were analyzed with the Cytovision system satellite within the LOXL1 gene, D15S154, D15S201, D15S158,
D15S1040, and a microsatellite near the NTRK3 gene (BP2-NTRK3).(Applied Imaging Ltd., UK). For each sample and probe, at least 20
metaphases were studied. FISH analysis of DUP25 was performed BP2-NTRK3 was identified from the sequence of a 1.5 kb BamHI
single-copy subclone of PAC 252A23, isolated using the 3	 endwith probes LOLG2 (a cosmid containing the LOXL1 gene), P216I14
(a PAC containing the 5	 region of NTRK3), YACs 802b4, 929c7, probe of NTRK3. The repeat sequence is (CA)24 and the primers were
BP2F, 5	-ttgcttgaagggcacctg-3	 and BP2R, 5	-aacatcctgggtacatgc-3	750b10, 891e7 and 753h11, and cosmids t216-1 and c251-3. Addi-
tional YACs within and outside the duplication were used to deter- (annealing at 58-65C). We considered equal allele frequencies for
each marker locus and performed two point calculations betweenmine the minimal extension of the duplication (Figure 5). A chromo-
some 21 probe (YAC 230e8) was used to assess the correct markers and the loci trait.
We used the Extended Relative Pair Analysis (ERPA) programcondensation of the chromatin.
Interphase FISH studies for 100 nuclei was performed with probes (Curtis and Sham, 1994) to perform a nonparametric analysis study-
ing all the possible pairs of affected individuals sharing the DUP25t216-1 and c251-3. The detection of mosaicism took into account
the efficiency of each probe in known diploid controls. Mosaicism alleles inherited IBD under the different models.
Association for 70 unrelated patients with a diagnosis of panicfor DUP25 was considered when more than 30% of the cells of a
given subject displayed three hybridization signals (Anastasis et al., disorder with or without agoraphobia, versus 189 control samples,
was measured by 2 calculations (Yate’s correction) and p values1990).
Collected sperm was first washed three times in PBS prior to were calculated using the Fisher exact test.
FISH. The sperm heads were decondensed, dehydrated through an
ethanol series (70%, 80%, 95%), and incubated for a maximum of Map Construction
10 min in DTT 5 mM at 37C. The extent of the 15q24-26 duplication was initially based on the
Sister chromatid exchange analysis was performed on peripheral YAC contig of chromosome 15 from the Whitehead Institute/MIT
blood cultures using 0.1 ml of 5-bromo-2	-deoxyuridine (BrdU) (3 Center for Genome Research. YACs and PACs were obtained from
mg/ml) and incubating at 37C for 70 hr. Slides were stained with the Jean Dausset-CEPH Foundation or from the UK HGMP. Clones
Hoescht 33258 (0.5 mg/ml) for 15 min and rinsed in water. Then, were confirmed to map to chromosome 15q24-26 by FISH and were
slides were mounted in MacIlvaine’s buffer and exposed to a black further characterized for STS content. Primers were acquired from
light bulb for 15 min resting on a 50C hot plate. Fifty cells were GenSet. The length of the duplicons was calculated with Pipmaker
scored for each patient. (http://bio.cse.psu.edu/pipmaker/) on masked sequences (http://
ftp.genome.washington.edu/RM/RepeatMasker.html). PCR amplifi-
cations were performed in 25 l reactions with 100 ng of template
Linkage and Association Studies
DNA and standard conditions, with annealing between 50C and
An autosomal dominant pattern of inheritance with incomplete pen-
65C.
etrance was considered. Penetrances were P  0.05 for genotype
/, allowing both for phenocopies or diagnosis errors; P  0.75
DNA Dosage Assessmentfor genotype /D and P  0.9 for D/D. DUP25 was entered in the
Genomic DNA from affected and normal individuals was digestedanalysis as an affection status or dichotomous locus type. To allow
with EcoRI. Southern blot analysis was performed according tothe inclusion of all the observed traits of this cytogenetic phenom-
standard protocols (Sambrook et al., 1989). For dosage assessment,ena, we considered the genotypes DUP/DUP, DUP/, or /; DUP
an EcoRI/SstI fragment of plasmid pNIJ3-SR0.4 containing the 400being the “deleterious duplicated allele.” We allowed for cytogenetic
bp of the 5	 end of the NTRK3 gene cDNA and a control markerdiagnostic errors due to probe efficiency or misinterpretation, by
from chromosome 2 (exon 7 of SCL3A1, probe E7-rBAT) were used.considering 3 liability classes (LC). LC1 represents the nondupli-
Dosage was assessed on autoradiographs using a densitometercated cases, with penetrances (P)  0.1 (/), 0.95 (/DUP), and
(Phoretix International, Newcastle, UK). Alternatively, dosage analy-0.99 (DUP/DUP). LC2 are cases diagnosed as “heterozygous dupli-
sis was assessed by simultaneous PCR amplification of the NTRK3cates” with P  0.05 (/), 0.90 (/DUP), and 0.05 (DUP/DUP). LC3
and PROC genes. PCR products were run on an ABI PRISM 377are “homozygous duplicates” with P  0.01 (/), 0.05 (/DUP),
DNA sequencer (PE Applied Biosystems) and data were analyzedand 0.90 (DUP/DUP). We also considered an “almost complete pen-
by Genotyper and Genescan softwares.etrance” model with P for LC1  0.01 (/), 0.99 (/DUP), and
0.999 (DUP/DUP); for LC2 P  0.001 (/), 0.99 (/DUP), and 0.01
Quantification of Human IL16 mRNA(DUP/DUP); and for LC3 P  0.001 (/), 0.01 (/DUP), and 0.99
Total RNA from cultured cell lines of affected and control individuals(DUP/DUP). We assumed the same values of disease (DUP) or wild-
was extracted as described (Sambrook et al., 1989). Competitivetype () allele frequencies (q) for both trait loci, and they were
PCR was as described (Celi et al., 1994). Briefly, endogenous IL16calculated according to the prevalence of the psychiatric phenotype
mRNA was amplified using primers corresponding to a 326 bp frag-or the detection of DUP25 in the control samples (q  0.075), which
ment (WI-7689) of the cDNA (forward primer, 5	-tcccataaccgctgave similar values and considered a mutation rate   105 to
gattctc-3	 and reverse primer, 5	-aataaatgtcactgtttggggg-3	). An in-allow for the possible de novo cases with respect to the psychiatric/
ternal standard (I.St.) was constructed by using the forward primerjoint laxity disorders.
and a reverse primer with 22 additional nucleotides, 76 nucleotidesWe performed two-point linkage analysis between the two loci
upstream of IL16. The resulting 228 bp PCR product, containing atraits using the function MLINK from the FASTLINK V2.2 software
deletion of 56 bp, was further subcloned in the pMOS Blue-T vectorpackage (Cottingham et al., 1993). The anxiety and joint laxity pheno-
(Amersham). RT-PCR was with 5 g of total RNA using the Super-types were studied under 11 models: (1) panic disorder/agorapho-
script system (Gibco-BRL). Coamplification of target and I.St. wasbia, (2) social phobia, (3) simple phobia, (4) panic disorder/agorapho-
with 1 l of the RT and varying amounts of the I.St. in a 20 l finalbia/social phobia, and (5) same as (4)/simple phobia; these five
volume. PCR controls for each sample were treated with 1 g ofmodels were also studied adding joint laxity; and this phenotype
RNAase A.was also tested alone. To avoid false positive linkage derived from
the different models tested, we used the more stringent criteria of
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